BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1379188)

  • 1. Processing and presentation of ovalbumin in mice genetically selected for antibody response.
    Vidard L; Rock KL; Couderc J; Mouton D; Benacerral B
    Eur J Immunol; 1992 Aug; 22(8):2165-8. PubMed ID: 1379188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability.
    Vidard L; Rock KL; Benacerraf B
    J Immunol; 1992 Sep; 149(6):1905-11. PubMed ID: 1517561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation to T cell lines and clones by peritoneal macrophages, peritoneal B cells and antigen-specific B cell hybridomas.
    Zimecki M; Abruzzini AF; Pierce CW; Kapp JA
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):409-22. PubMed ID: 2471477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing and presentation of type II collagen, a fibrillar autoantigen, by H-2q antigen-presenting cells.
    Manoury-Schwartz B; Chiocchia G; Fournier C
    Eur J Immunol; 1995 Dec; 25(12):3235-42. PubMed ID: 8566006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages, but not dendritic cells, present collagen to T cells.
    Michaëlsson E; Holmdahl M; Engström A; Burkhardt H; Scheynius A; Holmdahl R
    Eur J Immunol; 1995 Aug; 25(8):2234-41. PubMed ID: 7545114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors.
    Vidard L; Rock KL; Benacerraf B
    J Immunol; 1991 Sep; 147(6):1786-91. PubMed ID: 1890304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases.
    Vidard L; Rock KL; Benacerraf B
    J Immunol; 1992 Jul; 149(2):498-504. PubMed ID: 1378066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes.
    Stockinger B
    Eur J Immunol; 1992 May; 22(5):1271-8. PubMed ID: 1577067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
    Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
    Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different regulation of the L3T4-T cell subset by B cells in different mouse strains bearing the H-2k haplotype.
    Brinkmann V; Sharma SD; Remington JS
    J Immunol; 1986 Nov; 137(9):2991-7. PubMed ID: 2944967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific B cells efficiently present low doses of antigen for induction of T cell proliferation.
    Malynn BA; Romeo DT; Wortis HH
    J Immunol; 1985 Aug; 135(2):980-8. PubMed ID: 2409164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite-accessory cell interactions in theileriosis. Antigen presentation by Theileria annulata-infected macrophages and production of continuously growing antigen-presenting cell lines.
    Glass EJ; Spooner RL
    Eur J Immunol; 1990 Nov; 20(11):2491-7. PubMed ID: 2253687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific T helper clones in a nonresponder strain require augmentation for expression of helper activity. Evidence for a possible antigen presentation defect in B cells.
    Shastri N; Kawahara DJ; Miller A; Sercarz EE
    J Immunol; 1984 Sep; 133(3):1215-21. PubMed ID: 6205071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin.
    Diment S
    J Immunol; 1990 Jul; 145(2):417-22. PubMed ID: 1694878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in the beta chain of IAq versus IAp influences presentation of protein but not peptide antigens.
    Lambert LE; Berling JS; Thompson SD; Harton JA; Bishop GA; Choi E
    Cell Immunol; 1995 Oct; 165(2):202-10. PubMed ID: 7553884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell activation potential of insulin-reactive T cells in H-2b mice.
    Huber BT; Hochman PS
    Eur J Immunol; 1984 Dec; 14(12):1106-10. PubMed ID: 6083870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen.
    Shimonkevitz R; Colon S; Kappler JW; Marrack P; Grey HM
    J Immunol; 1984 Oct; 133(4):2067-74. PubMed ID: 6332146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
    Kawamura H; Berzofsky JA
    J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro immune response of spleen cells from mice genetically selected for high or low antibody production.
    Doria G; Agarossi G; Biozzi G
    Immunology; 1978 Jun; 34(6):999-1005. PubMed ID: 98427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.
    Casten LA; Pierce SK
    J Immunol; 1988 Jan; 140(2):404-10. PubMed ID: 2447176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.